Edinburgh Research Explorer

Dr Sally Argyle

(Former employee or visitor)

  1. 2019
  2. A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes

    Rafferty, R., Robinson, V., Harris, J., Argyle, S. & Nuttall, T., 30 Oct 2019, In : BMC Veterinary Research. 15, 1, p. 382

    Research output: Contribution to journalArticle

  3. 2018
  4. Antibiotic prophylaxis in veterinary cancer chemotherapy: a review and recommendations.

    Bisson, J., Argyle, D. & Argyle, S., Sep 2018, In : Veterinary and Comparative Oncology. 16, 3, p. 301-310

    Research output: Contribution to journalLiterature review

  5. 2017
  6. Convergence of plasmid architectures drives emergence of multi-drug resistance in a clonally diverse Escherichia coli population from a veterinary clinical care setting

    Wagner, S., Lupolova, N., Gally, D. & Argyle, S., Nov 2017, In : Veterinary Microbiology. 211, p. 6-14

    Research output: Contribution to journalArticle

  7. A perspective from Edinburgh: When it comes to student selection, does the interview do what we think and what we want?

    Phillips, C., Argyle, S., Handel, I. & Rhind, S., 11 Mar 2017, 2017 AAVMC Annual Conference and Iverson Bell Symposium.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  8. 2016
  9. Phylogenomic approaches to determine the zoonotic potential of Shiga toxin-producing Escherichia coli (STEC) isolated from Zambian dairy cattle

    Mainda, G., Lupolova, N., Sikakwa, L., Bessell, P. R., Muma, J. B., Hoyle, D. V., McAteer, S. P., Gibbs, K., Williams, N. J., Sheppard, S. K., La Ragione, R. M., Cordoni, G., Argyle, S. A., Wagner, S., Chase-Topping, M. E., Dallman, T. J., Stevens, M. P., Bronsvoort, M. & Gally, D. L., 25 May 2016, In : Scientific Reports. 6, 26589.

    Research output: Contribution to journalArticle

  10. Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides

    Fernandez-brando, R., Yamaguchi, N., Tahoun, A., Mcateer, S. P., Gillespie, T., Wang, D., Argyle, S. A., Palermo, M. S. & Gally, D. L., Jan 2016, In : Antimicrobial Agents and Chemotherapy. 60, 1, p. 459–470

    Research output: Contribution to journalArticle

  11. 2015
  12. Prophylactic use of antimicrobials in surgical pig models; a literature review (2012-2014)

    Bradbury, A. G., Argyle, S., Eddleston, M. & Clutton, R. E., 4 Jul 2015, In : Veterinary Record. 177, 1, p. 16-21 6 p.

    Research output: Contribution to journalLiterature review

  13. 2014
  14. The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro

    Pang, L. Y., Argyle, S. A., Kamida, A., Morrison, K. ON. & Argyle, D. J., 5 Sep 2014, In : BMC Veterinary Research. 10, 1, p. 184 11 p., 184.

    Research output: Contribution to journalArticle

  15. Multidrug-resistant Escherichia coli from canine urinary tract infections tend to have commensal phylotypes, lower prevalence of virulence determinants and ampC-replicons

    Wagner, S., Gally, D. L. & Argyle, S. A., 14 Mar 2014, In : Veterinary Microbiology. 169, 3-4, p. 171-178

    Research output: Contribution to journalArticle

Previous 1 2 3 Next